SciClone Pharmaceuticals
SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company headquartered in Foster City, California, that focuses on developing and commercializing therapies for oncology, infectious diseases, and cardiovascular disorders. The company's lead product, ZADAXIN, is utilized for treating hepatitis B and C, certain cancers, and enhancing immune function, with ongoing development for treating sepsis. In addition to ZADAXIN, SciClone offers a range of products including DC Bead, which is approved for liver cancer treatment in multiple countries, and ondansetron RapidFilm, used to manage nausea and vomiting related to chemotherapy and surgery. The company has established strategic partnerships to promote various products, such as Angiomax and Cleviprex. SciClone’s integrated platform emphasizes rapid growth in therapeutic areas with significant unmet medical needs, particularly in China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.